Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study-Reference-Cited by-同舟云学术

Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study

Published:2017-12-21 Issue:2 Volume:35 Page:243-253
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Lapolla Annunziata, ,Berra Cesare,Boemi Massimo,Bossi Antonio Carlo,Candido Riccardo,Di Cianni Graziano,Frontoni Simona,Genovese Stefano,Ponzani Paola,Provenzano Vincenzo,Russo Giuseppina T.,Sciangula Luigi,Simioni Natalino,Bette Cristiano,Nicolucci Antonio^ORCID

Funder

Novo Nordisk

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-017-0652-2.pdf

Reference21 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79.

2. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–9.

3. Hankinson AL. Epidemiologic and pathophysiologic links between obesity and hypertension. Curr Cardiovasc Risk Reps. 2009;3:264–71.

4. World Health Organization. Global strategy on diet, physical activity and health: obesity and overweight. 2017. http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf . Accessed 27 Sept 2017.

5. Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012;8:728–42.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Efficacy and Safety of Glucagon-Like Peptide 1 (GLP-1) Agonist Versus Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors in Chinese Patients with Type 2 Diabetes Mellitus: A Preliminary Study;International Journal of Pharmacology;2024-05-01

2. Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets;American Journal of Physiology-Endocrinology and Metabolism;2023-11-01

3. AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus;Acta Diabetologica;2023-06-04

4. Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01);Frontiers in Endocrinology;2023-01-18

5. AWARE. A web application to rapidly assess cardiovascular risk in Type 2 Diabetes Mellitus.;2022-12-28